Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Rapid Dose Therapeutics Corp. (RDTCF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.02000.0000 (0.00%)
At close: 10:42AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0200
Open0.0200
BidN/A x N/A
AskN/A x N/A
Day's Range0.0200 - 0.0200
52 Week Range0.0200 - 1.1100
Volume200
Avg. Volume3
Market Cap6.987M
Beta (5Y Monthly)1.66
PE Ratio (TTM)N/A
EPS (TTM)-0.0170
Earnings DateJan 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RDTCF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • RAPID DOSE THERAPEUTICS CORP
    Analyst Report: STERIS plcSteris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
    Rating
    Fair Value
    Economic Moat
    3 months agoMorningstar
View more
Advertisement
Advertisement